Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Yvonne Bonomo

Biographic Data

ID1945394
NAMEYvonne Bonomo
GIVEN NAMESYvonne
FAMILY NAMEBonomo
SIGNATUREBONOMO Y
AFFILIATIONSSt Vincent's Hospital Melbourne
ORCID0000-0003-2583-0687
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS1
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX1
  • A case of severe and prolonged γ‐hydroxybutyrate ( GHB ) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper

    Open Access•Rachit Gupta, Greta Moon et al.•ARTICLE•Drug and Alcohol Review•2025

  • DMT and harmala alkaloids

    Open Access•Yvonne Bonomo, Yvonne A Bonomo et al.•ARTICLE•Frontiers in Psychiatry•2025

    https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384191&isReview=true, identifier ACTRN12622001315707

  • The therapeutic potential of including songs that reference drugs and alcohol during music therapy for adults undergoing substance withdrawal

    Open Access•Jennifer Bibb, Michelle Hines et al.•ARTICLE•Nordisk Tidsskrift for Musikkterapi•2025•Cited by: 1•References: 22

  • Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances

    Open Access•Melissa A Jackson, Amanda Brown et al.•ARTICLE•Frontiers in Psychiatry•2023

    https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374196, ACTRN1261800056224

  • The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022

    Open Access•Christine Mary Hallinan, Yvonne Bonomo•ARTICLE•International Journal of…•2022

    Medicinal cannabis was legalised in Australia in November 2016. By August 2022, there were 5284 specialist physician and general practitioner (GP) prescribers who submitted Special Access Scheme (SAS) applications to the Therapeutic Goods Administration (TGA) for the provision of medicinal cannabis prescriptions their patients. In this article we examine the impact of the delivery of publicly available clinical guidance documents, provision of ed…

  • The development and implementation of a rapid‐access long‐acting injectable buprenorphine clinic in metropolitan Melbourne during the Covid ‐19 pandemic

    Open Access•Adam Straub, Adam Pastor et al.•ARTICLE•Drug and Alcohol Review•2021

    Transmitting via droplets, contact and potentially aerosolised particles [1], the current COVID-19 pandemic presents a number of challenges for ensuring the safety of people seeking opioid agonist treatment (OAT) and their health-care providers [2, 3]. Specifically, the requirement for frequent attendances to a pharmacy, where contact with other members of the community is inevitable, poses increased risk and stigma from accessing treatment to pe…

  • Early development of an integrated oral health (OH) care program with people who inject drugs (PWID) in a primary health care setting

    Open Access•Ana Ivanovic, Rachel Martin et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

  • The therapeutic potential of including songs that reference drugs and alcohol during music therapy for adults undergoing substance withdrawal

    Open Access•Jennifer Bibb, Michelle Hines et al.•ARTICLE•Nordisk Tidsskrift for Musikkterapi•2025•Cited by: 1•References: 22

  • Early development of an integrated oral health (OH) care program with people who inject drugs (PWID) in a primary health care setting

    Open Access•Ana Ivanovic, Rachel Martin et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

  • The development and implementation of a rapid‐access long‐acting injectable buprenorphine clinic in metropolitan Melbourne during the Covid ‐19 pandemic

    Open Access•Adam Straub, Adam Pastor et al.•ARTICLE•Drug and Alcohol Review•2021

    Transmitting via droplets, contact and potentially aerosolised particles [1], the current COVID-19 pandemic presents a number of challenges for ensuring the safety of people seeking opioid agonist treatment (OAT) and their health-care providers [2, 3]. Specifically, the requirement for frequent attendances to a pharmacy, where contact with other members of the community is inevitable, poses increased risk and stigma from accessing treatment to pe…

  • The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022

    Open Access•Christine Mary Hallinan, Yvonne Bonomo•ARTICLE•International Journal of…•2022

    Medicinal cannabis was legalised in Australia in November 2016. By August 2022, there were 5284 specialist physician and general practitioner (GP) prescribers who submitted Special Access Scheme (SAS) applications to the Therapeutic Goods Administration (TGA) for the provision of medicinal cannabis prescriptions their patients. In this article we examine the impact of the delivery of publicly available clinical guidance documents, provision of ed…

  • Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances

    Open Access•Melissa A Jackson, Amanda Brown et al.•ARTICLE•Frontiers in Psychiatry•2023

    https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374196, ACTRN1261800056224

  • A case of severe and prolonged γ‐hydroxybutyrate ( GHB ) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper

    Open Access•Rachit Gupta, Greta Moon et al.•ARTICLE•Drug and Alcohol Review•2025

  • DMT and harmala alkaloids

    Open Access•Yvonne Bonomo, Yvonne A Bonomo et al.•ARTICLE•Frontiers in Psychiatry•2025

    https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384191&isReview=true, identifier ACTRN12622001315707

  • The therapeutic potential of including songs that reference drugs and alcohol during music therapy for adults undergoing substance withdrawal

    Open Access•Jennifer Bibb, Michelle Hines et al.•ARTICLE•Nordisk Tidsskrift for Musikkterapi•2025•Cited by: 1•References: 22

Medicine (6 works) · Psychiatry (3 works) · Abstinence (2 works) · Family medicine (2 works) · Forensic Toxicology and Drug Analysis (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Internal Medicine (2 works) · Pharmacology (2 works) · Psychedelics and Drug Studies (2 works) · 2019-20 coronavirus outbreak (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae